![Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India - eClinicalMedicine Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India - eClinicalMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e7a2e829-a8a6-4767-9da1-8e764d5c37ae/gr1.jpg)
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India - eClinicalMedicine
![Your "no route to host" while the machine is ping-able is the sign of a firewall that denies you access politely (i.e. with an ICMP mess… | Route, Hosting, Messages Your "no route to host" while the machine is ping-able is the sign of a firewall that denies you access politely (i.e. with an ICMP mess… | Route, Hosting, Messages](https://i.pinimg.com/originals/d3/73/7a/d3737aa1c2731dd590c1e5f9a381249c.png)
Your "no route to host" while the machine is ping-able is the sign of a firewall that denies you access politely (i.e. with an ICMP mess… | Route, Hosting, Messages
![Scalable two-step annealing method for preparing ultra-high-density single-atom catalyst libraries | Nature Nanotechnology Scalable two-step annealing method for preparing ultra-high-density single-atom catalyst libraries | Nature Nanotechnology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41565-021-01022-y/MediaObjects/41565_2021_1022_Fig1_HTML.png)
Scalable two-step annealing method for preparing ultra-high-density single-atom catalyst libraries | Nature Nanotechnology
![High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway | Nature Communications High doses of CpG oligodeoxynucleotides stimulate a tolerogenic TLR9–TRIF pathway | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncomms2874/MediaObjects/41467_2013_Article_BFncomms2874_Fig1_HTML.jpg)